Group One Trading
BHVN

Group One Trading’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Group One Trading’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-3,881
Closed -$575K – 8740
2022
Q2 		$566K Sell
3,881
-7,699
-66% -$983K ﹤0.01% 3295
2022
Q1 		$1.37M Buy
+11,580
New +$1.44M ﹤0.01% 2771
2021
Q1 		– Sell
-38,581
Closed -$3.12M – 8350
2020
Q4 		$3.31M Buy
38,581
+27,752
+256% +$2.35M 0.01% 1627
2020
Q3 		$704K Buy
10,829
+1,649
+18% +$108K ﹤0.01% 2538
2020
Q2 		$671K Sell
9,180
-3,349
-27% -$178K ﹤0.01% 2381
2020
Q1 		$426K Sell
12,529
-41,975
-77% -$1.92M ﹤0.01% 2168
2019
Q4 		$2.97M Sell
54,504
-33,917
-38% -$1.68M 0.02% 988
2019
Q3 		$3.69M Sell
88,421
-14,426
-14% -$609K 0.03% 776
2019
Q2 		$4.5M Buy
+102,847
New +$5.8M 0.04% 584
2018
Q4 		– Sell
-1,702
Closed -$61.4K – 5959
2018
Q3 		$64K Sell
1,702
-3,202
-65% -$118K ﹤0.01% 3833
2018
Q2 		$194K Sell
4,904
-61,596
-93% -$1.95M ﹤0.01% 3072
2018
Q1 		$1.71M Buy
+66,500
New +$1.99M 0.02% 1119

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Group One Trading's BHVN Position: Q3 2022 in Review

Group One Trading sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q3 2022, closing a stake of 3,881 shares — an estimated $575K sold.

Group One Trading first reported a position in BHVN in Q1 2018 and held it in 12 quarters. The position peaked at $4.5M in Q2 2019. 240 funds tracked by Wall St. Rank hold BHVN as of Q3 2022.

  • Group One Trading reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q3 2022 after selling out during the quarter.
  • Group One Trading sold 3,881 Biohaven Pharmaceutical Holding Company Ltd. shares in Q3 2022, an estimated $575K.
  • Group One Trading first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q1 2018 and held it in 12 quarters.
  • Group One Trading's Biohaven Pharmaceutical Holding Company Ltd. position peaked at $4.5M in Q2 2019.
  • 240 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q3 2022.

Based on Group One Trading's 13F filing for Q3 2022, filed 9 Nov 2022.